Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prediction of Excretion and Toxicity of High Dose Methotrexate in Children and Adolescents With ALL
NCT02133599Completed
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Start
- Jul 2014
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of iohexol in acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL), sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. Primary endpoint: Change in Iohexol clearance results at 6 weeks. Started Jul 2014; status: completed.
02
Drugs
iohexol
03
Conditions
acute lymphoblastic leukemia (ALL)lymphoblastic lymphoma (LBL)
Beyond the preview
Go deeper on NCT02133599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02133599.